PharmaCyte Biotech PMCB
NASDAQ PMCB
$0.40 -0.01 (-1.63%)
As of: Oct 1, 2026 · 3:59 PM EDT

PharmaCyte Biotech (PMCB) Non-Current Debt (2020 - 2021)

Updated

PharmaCyte Biotech's Non-Current Debt was $75,200 in fiscal Q3 2021 (quarter ended Jan 31, 2021), unchanged from the prior quarter.

Analysis

PharmaCyte Biotech (PMCB) Non-Current Debt (2020 - 2021) Analysis & Trends

At the end of FY2020 (ended Apr 30, 2020), Non-Current Debt at PharmaCyte Biotech came in at $46,282.

  • Per Business Quant data, PMCB's Non-Current Debt in the three fiscal quarters before Q3 2021 was $75,200 (Q2 2021), $75,200 (Q1 2021) and $46,282 (Q4 2020).
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Non-Current Debt (Qtr)
1 Johnson & Johnson 638.12 Bn 556.64 Bn 17.26 Bn 37.34 Bn
2 AbbVie 462.60 Bn 435.75 Bn 12.70 Bn 62.48 Bn
3 Merck 358.70 Bn 313.13 Bn 12.21 Bn 51.08 Bn
4 Novartis Ag 272.16 Bn 228.03 Bn 11.24 Bn -
5 Astrazeneca 250.36 Bn 223.92 Bn 12.86 Bn -108.00 Mn
6 Amgen 227.87 Bn 183.27 Bn 7.24 Bn 51.86 Bn
7 Gilead Sciences 184.97 Bn 159.08 Bn 6.22 Bn 23.83 Bn
8 Pfizer 162.61 Bn 109.56 Bn 10.94 Bn 60.50 Bn
9 Vertex Pharmaceuticals 132.45 Bn 104.46 Bn 2.84 Bn -
10 PharmaCyte Biotech 4.40 Mn 4.40 Mn - -
Historic Data

Historic Data

Download Data
DateValue
Jan 31, 2021 75,200.00
Oct 31, 2020 75,200.00
Jul 31, 2020 75,200.00
Apr 30, 2020 46,282.00
API Access

PharmaCyte Biotech Non-Current Debt API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=non-current-debt&ticker=PMCB&period=max&api_key=YOUR_API_KEY